generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.

 

But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs (including hydroxychloroquine) to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.

 

Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications– like hydroxychloroquine – to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.

 

Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.

 

Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.

 

Call: +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

pharmaceutical company in India
Pharmaceutical Company

The Leading Pharmaceutical Company in India to Provide a Range of Medications and Additional Services

The WHO GMP certified companies in India are working continuously towards enhancement of the affordability of the medicines by investing in the manufacturing capital that facilitates the point of C GMP compliance as well as global approval.

Over the years, the team members had built confidence and now there has been a constant as well as timely delivery of dependable products. The manufacturers are continuously striving for retaining the standards by manufacturing high-quality medicines that also take into consideration the implementation of the innovative as well as the path-breaking technologies for delivery of the superior quality products. They always use stringent practices for the generic medicine export from India. Presently, there are plenty of products that fall under the category of generic medicine export from India along with the therapeutic category. Besides, the licensed facilities that support both the generic as well as the biotic business makes them stand out. There has been a better development of the new drug delivery with the facilitation of the infrastructure that supports the API as well as the formulation of the development and strengthening of the platform technologies.

A highlight on Joinhub Pharma

Over the years, the company’s Joinhub Pharma has been working on the achievement of high-quality standards in the pharmaceutical industry. There is a quality management system that adheres to the scientific solutions with the use of innovative products designed for the improvement of quality of life. The fully integrated pharmaceutical company is striving for providing the list of medications available at affordable prices.

The aspiring pharmaceutical company now excels in the selling of analgesics, anti-infectives, antibiotics, Critical Care antibiotics, nutritional products, antioxidants, protein powders, Gastro medicines, and everything else. So, there is the sourcing of reliable products from reliable vendors who ensure that their clients are getting the best quality products. Besides, there are also options for the customers to avail of the range of the comparatively low priced medicines.

What makes the services stand out?

  • The team of experts always pays attention to quality for remaining on the top of the priority list that makes them offer high standard products to the consumers.
  • The workers always pay attention to the timely delivery of your order. So, you can rest assured that they will be delivering it at the needed time.
  • With the wide range of products that will be getting from the teams, you can rest assured that there are a variety of illnesses that can be solved with them.
  • The largest pharmaceutical manufacturing company is now having the qualified as well as experience team for taking care of the manufacturing and supplying of all kinds of tablets, capsules, syrups, ointments, dry syrup, as well as the herbal medicine.
  • The company also implies to the requirements laid down by the schedule M GMP of the drugs and cosmetics act. Overall, there is a constant focus on the quality standards for the maintenance of the record check.
  • They are always committed to providing excellence. They always undertake strategies for the improvement of the products in every possible manner. They always find the rights quotes for the improvement and achievement of their objective.
  • The team also comprises of the highly qualified teams of experts and scientists who work together throughout the research and development activities. The team always takes into consideration finding better alternatives for the development of the expensive and less feasible product.
  • They also take special care in the estimation of the quality of maternal health care products. In addition to that, they strive for enhancing the experience and keep working on the transformative solutions for the secured will being.

Newness in the pharmaceutical field

The pharmaceutical company, Joinhub Pharma is one of the top generic pharma companies in India and develops the indispensable tool that is helping them to move forward in terms of the manufacturing of the new medical standards. Besides, the RND Laboratories along with the Clinical Research organizations are ensuring that they stand ahead in terms of the discovery of the immunoassay kits, reagents, systems, as well as customer services. Besides, they make use of the technology standards for enabling the precise measurement of the molecules at every level for the development of the biomarker. The scientists have familiarity with additional immunoassays that also works with the combination of a traditional workflow with patented technology.

A responsible group of professionals

Joinhub Pharma, the Indian pharmaceutical company is spanning as a network of the facilities that are seeking the expansion of the vision both horizontally as well as vertically. Besides, the pharmaceutical company in India units is also setting compliance with environmental hazards based norms. The pollution-free company is now taking responsibility for developing a good network of pharmaceutical companies in India in a better way. It makes use of the state-of-the-art missionary as well as equipment. Overall, there is the friendly best pharmaceutical manufacturing unit that is spanning in the domestic market. The leading pharmaceutical company is now placed in terms of offering the largest portfolio of the effective as well as safe generic products that can cover the major therapeutic categories.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK